Cardio Diagnostics Holdings Inc (CDIO) concluded trading on Thursday at a closing price of $0.68, with 4.92 million shares of worth about $3.35 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 61.26% during that period and on February 13, 2025 the price saw a gain of about 27.03%. Currently the company’s common shares owned by public are about 40.44M shares, out of which, 36.50M shares are available for trading.
Stock saw a price change of 49.25% in past 5 days and over the past one month there was a price change of 18.70%. Year-to-date (YTD), CDIO shares are showing a performance of -26.14% which decreased to -64.91% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $0.19 but also hit the highest price of $1.91 during that period. The average intraday trading volume for Cardio Diagnostics Holdings Inc shares is 6.33 million. The stock is currently trading 32.97% above its 20-day simple moving average (SMA20), while that difference is down -4.08% for SMA50 and it goes to 32.86% higher than SMA200.
Cardio Diagnostics Holdings Inc (NASDAQ: CDIO) currently have 40.44M outstanding shares and institutions hold larger chunk of about 4.56% of that.
The stock has a current market capitalization of $35.31M and its 3Y-monthly beta is at 3.54. It has posted earnings per share of -$0.38 in the same period. It has Quick Ratio of 8.51 while making debt-to-equity ratio of 0.20. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for CDIO, volatility over the week remained 19.48% while standing at 16.19% over the month.
Analysts are in expectations that Cardio Diagnostics Holdings Inc (CDIO) stock would likely to be making an EPS of -0.06 in the current quarter, while forecast for next quarter EPS is -0.06 and it is -0.23 for next year. For the current quarter EPS, analysts have given the company a lowest target -0.06 which is -0.06 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -1.06 in the same quarter a year ago. Stock’s fiscal year EPS is expected to rise by 45.45% while it is estimated to increase by 36.11% in next year.
